Net Income (Loss) Per Share - Schedule of Weighted Average Impact of Potentially Dilutive Securities (Details) - shares shares in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities (in shares) | 91,210 | 75,334 |
| Employee share-based awards | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities (in shares) | 52,150 | 55,313 |
| Unvested RSAs | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities (in shares) | 1,462 | 84 |
| CEO Equity Award | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities (in shares) | 28,960 | 19,937 |
| Stock options | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities (in shares) | 8,638 | 0 |